Work

First-in-Human Phase I Trial Combining Biologically Guided Radioimmunotherapy (RIT) Using a 90Y-Anti-CD25 Monoclonal Antibody (Mab) with CT-guided Total Marrow and Lymphoid Irradiation (TMLI) in Relapsed and Refractory (R/R) Acute Leukemia

Year: 2023

Type: article

Study design: Clinical Trial

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2023.06.256

Authors: J.Y.C. Wong, A.M. Monzr, F. Sahebi, S.V. Dandapani, D.M. Yamauchi, A. Salhotra, V. Adhikarla, H. Ali, E. Poku, D. Yang, C. Han, A. Liu, S. Mokhtari, A. Wu, P. Yazaki, J.E. Shively, S.K. Hui, E. Smith, A. Stein

Institutions: City Of Hope National Medical Center, City of Hope, Beckman Research Institute

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4387207675

FWCI: 0.294

Cites:

Cited by: 2

Related to: 10